6533b85cfe1ef96bd12bcbaa
RESEARCH PRODUCT
Commissioning and periodic tests of the Esteya® electronic brachytherapy system
C. Candela-juanJavier VijandeJose Perez-calatayudFacundo BallesterZoubir OuhibYury Niatsetskisubject
Review Papermedicine.medical_specialtyTraceabilityPeriodic testingelectronic brachytherapybusiness.industryProject commissioningmedicine.medical_treatmentBrachytherapyquality assuranceTest (assessment)EsteyaOncologyAcceptance testingRadiation oncologyMedicinecommissioningRadiology Nuclear Medicine and imagingMedical physicsbusinessQuality assurancedescription
A new electronic brachytherapy unit from Elekta, called Esteya(®), has recently been introduced to the market. As a part of the standards in radiation oncology, an acceptance testing and commissioning must be performed prior to treatment of the first patient. In addition, a quality assurance program should be implemented. A complete commissioning and periodic testing of the Esteya(®) device using the American Association of Physicists in Medicine (AAPM), Groupe Europeen de Curietherapie and the European Society for Radiotherapy & Oncology (GEC-ESTRO) guidelines for linacs and brachytherapy units as well as our personal experience is described in this paper. In addition to the methodology, recommendations on equipment required for each test are provided, taking into consideration their availability and traceability of the detectors. Finally, tolerance levels for all the tests are provided, and a specific frequency for each test is suggested.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-03-18 | Journal of Contemporary Brachytherapy |